baber/WOPTO huggingface dataset:
Patent FI-894649-A0 (FI)
Inventor: DELAROCHE JEAN-PAUL
IPC: D21D1/32
Filed: 1989-10-02
Abstract: Process for mechanical fibre removal from a lignocellulose material obtained by a preliminary impregnation treatment of chippings by a reagent which promotes softening of the lignin. Said process is characterized in that it consists in passing the material through an apparatus (20) of the crusher type with hammers and a cylindrical grid. This process ensures that the pulp obtained has a maximum of long fibres. The process also offers a lower energy consumption than in conventional disk-type refiners.
Patent FI-902732-A0 (FI)
Inventor: GRETER ANDREAS
IPC: G01N1/10
Filed: 1990-06-01
Abstract: Pipetting insert (11) for a pipetting device for taking a liquid sample (12) from a vacuum tube (13) which is closed airtight by a stopper (14). 
<??>To preclude an undesired escape of sample fragments from the vacuum tube before sampling, the pipetting insert is characterised in that
 a) it consists of a plastic,
 b) it has an elongate body which has at one end a conical part (15), at the other end a hollow tip (17) which is formed by a wall (18) which can be pierced by a pipetting needle and, in between, a middle tubular part (16),
 c) the middle part (16) of the body has, along its longitudinal axis (Z-Z) a bore (21) which connects the interior (22) of the conical part (15) to the interior (23) of the hollow tip (17), and
 d) the outer wall (24) of the middle part (16) of the body contains at least one connecting channel (25) which extends between the conical part (15) and the tip (17) and whose cross-section is substantially smaller than the cross-section of the bore (21) of the middle part (16) of the body. 
<IMAGE>
Patent FI-904452-A0 (FI)
Inventor: RIFI MAHMOUD RASHAD
IPC: C08F210/18
Filed: 1990-09-10
Abstract: A process for the production of EPDM comprising reacting ethylene, propylene, ethylidene norbornene, and hydrogen, in the gas phase, in a fluidized bed, under polymerization conditions, in the presence of a catalyst system comprising:   (a) the reaction product of a vanadium compound and a electron donor;   (b) at least one modifier having the formula BX3 or AlR(3-a)Xa wherein each R is alkyl or aryl and alike or different; each X is independently chlorine, bromine, or iodine; and a is 0, 1, or 2, wherein components (a) and (b) are impregnated into an inorganic support;     (c) a halocarbon promoter; and   (d) a hydrocarbyl aluminum cocatalyst  with the following proviso:   (i) the partial pressure of ethylene is in the range of about 25 to about 200 psi; (ii) the molar ratio of propylene to ethylene is in the range of about 0.2:1 to about 2:1; (iii) the molar ratio of hydrogen to ethylene is in the range of about 0.0001:1 to about 0.01:1; and (iv) the amount of ethylidene norbornene is about 1.5 to about 15 percent by weight based on the weight of the fluidized bed.
Patent FI-904464-A0 (FI)
Inventor: CHAI CHANG-SHUNG
IPC: B23K35/40
Filed: 1990-09-10
Abstract: A consumable welding element for arc welding comprising a steel sheath surrounding a compacted core containing metal alloying powders and an essentially 100% basic compound in an amount less than about 1.60% of the total weight of said element. The basic compound is calcium fluoride powder which is preferably in the range of about 0.1% to about 0.9% calcium fluoride powder by total weight of the element. As another feature the core of the element contains a specific agent for decreasing the amount of diffusible hydrogen in the weld metal. This new element may be a filler metal for TIG welding; however, it is preferably a consumable electrode for MIG welding.
Patent FI-921544-A0 (FI)
IPC: B61D3/18
Filed: 1992-04-08
Abstract: The invention relates to a railway freight wagon for transporting semi-trailers for road vehicles, which semi-trailers can be lifted by crane and have at least one pocket (6) which is located at a lower position with respect to the outer side members (1) of the underframe of the freight wagon for the purpose of holding the wheels of a semi-trailer and having at least one support block (8) which serves to receive the kingpin of the semi-trailer and can be displaced in the longitudinal direction of the wagon on a sliding track (9) running over the displacement area. In order to further develop a railway freight wagon of the type defined above in such a way that the entire length of the wagon is available for loading the railway freight wagon, it is proposed that a loading table (12) be arranged at the end of the sliding track (9), onto which table the support block (8) can be pushed, it being possible to swivel the said table into a position in which it clears the loading surface (11) defined by the upper side of the outer side members (1). <IMAGE>
Patent FI-924278-A0 (FI)
Inventor: MOORE KEVIN W
IPC: A61K38/00
Filed: 1992-09-24
Abstract: A method of treating EBV infections is provided. The method comprises administering an effective amount of an monoclonal antibody antagonist to the EBV protein, BCRF1. Preferably, the antagonist is a blocking monoclonal antibody specific for BCRF1, or a fragment or binding composition derived therefrom.
Patent FI-931390-A0 (FI)
Inventor: LUESSI ANDRE
IPC: A47J31/36
Filed: 1993-03-26
Abstract: The expulsion device comprises an expulsion member (17) which is attached pivotably to a brewing cylinder (9) arranged so as to be displaceable along a parallel drive spindle (6), and a projection (22) arranged in the lower region on a side piece (2) of a frame (1). A second plunger (8), mounted displaceably in the brewing cylinder (9), is displaceable during a downward movement of the brewing cylinder (9) up to the one upper end of the latter. Ground coffee (40), which has been compressed to form a cake, is conveyed out of the brewing cylinder (9) during this displacement movement. It rests on the embossed end face (42) of the second plunger (8). The expulsion member (17) comprises two pivoting levers (18, 19) which extend along the sides of the brewing cylinder (9). They are mounted in the lower region of the brewing cylinder (9) so as to be pivotable about a pivot axis (23). The ends of the pivoting levers (18, 19) facing away from the pivot axis are connected to an expulsion plate (20). One of the pivoting levers has an L-shaped continuation (21). The latter acts, together with the projection (22), as actuating means for pivoting out the expulsion member (17). Due to the fact that both the one end (41) of the brewing cylinder (9) and the end face (42) of the second plunger (8) are curved and matched to one another in such a way that a sliding surface (50) of the expulsion plate (20) rubs over the surfaces (41, 42) virtually without gaps during the pivoting of the expulsion member (17), the cake can be scraped off without any appreciable residues of ground coffee remaining. <IMAGE>
Patent FI-935922-A0 (FI)
Inventor: DILLA WOLFGANG
IPC: C02F1/76
Filed: 1993-12-29
Abstract: The present invention relates to a process for decreasing the content of organic chemical substances in waste waters by chemical oxidation, preferably in the presence of chlorine, and, if required, additional alkaline thermal treatment of the waste water, the waste water (effluent), which has a COD content (chemical oxygen demand) and an alkalinity or is made alkaline, being passed into at least one reactor and being treated at a temperature of above 15@C with a chlorine-containing and/or chlorine-releasing chemical substance, the chlorine input being in an amount of more than 1 g of chlorine/g of COD (based on the chlorine content of the chlorine-containing and/or chlorine-releasing chemical substance) and a molar ratio of OH<-> to chlorine of greater than 1.5 and a pH of the waste water of >/= 5, preferably >/= 6, being maintained or established, and the chlorine-treated waste water being subjected to a reaction time of more than 0.25 hours, preferably more than 0.4 hours, the organic compounds being at least partially oxidised and the waste water then being further treated and/or discharged or drained from the reactor.
Patent FI-944979-A0 (FI)
Inventor: DE JONG JOHANNES
IPC: B66B13/30
Filed: 1994-10-21
Abstract: Sill system for an elevator car, comprising a sill profile (5), a lower door guide (7) movable in a slot (12) in the sill profile (5) and a guide holding bracket (9) for connecting the lower door guide (7) to the door. The guide holding bracket (9) is passed to the lower door guide (7) from below the surface level of the car floor (3). <IMAGE>
Patent FI-945301-A0 (FI)
Inventor: PEDERSEN THOR
IPC: B65D88/12
Filed: 1994-11-10
Abstract: PCT No. PCT/SE93/00387 Sec. 371 Date Nov. 9, 1994 Sec. 102(e) Date Nov. 9, 1994 PCT Filed May 4, 1993 PCT Pub. No. WO93/23315 PCT Pub. Date Nov. 25, 1993A foldable container comprising a floor (11), a roof (10), and at least two side-walls (12-15). Each one of the side walls (12-15) is connected with the floor (11) through link members (27) forming a connection between the edge side (20) of the floor and the lower edge side of respective side wall (12-15). The link members allow on one hand turning the wall between a horizontal position and a vertical position, and on the other hand displacing the wall in its own plane.
Patent FI-956334-A0 (FI)
Inventor: BAIOCCHI LEANDRO
IPC: A61K31/495
Filed: 1995-12-29
Abstract: (S) or (R) enantiomer of a compound of formula: where Alk is an alkyl having from 1 to 3 carbon atoms, and an acid addition salt thereof with a physiologically acceptable acid.
Patent FI-961124-A0 (FI)
Inventor: WILKINS LEON M
IPC: A01N1/02
Filed: 1996-03-11
Abstract: This invention is directed to cryopreservation of cultured tissue equivalents made by in vitro technology. The invention involves immersing a cultured tissue equivalent in a cooled cryoprotectant solution, agitating the cryoprotectant solution and the immersed cultured tissue to achieve effective penetration of the cryoprotectant solution into the cultured tissue equivalent, and then freezing the cultured tissue at a high freezing rate. The cryopreserved cultured tissue equivalent may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro.
Patent FI-962798-A0 (FI)
Inventor: GRANT PETER LEONARD
IPC: C12Q1/6818
Filed: 1996-07-09
Abstract: An assay for a target nucleotide sequence in a sample, comprises bringing into contact with the sample first and second nucleotide probes respectively labelled with first and second enzymes of a channelling pair, and wherein the probes hybridize at closely adjacent sites on the target sequence in such a way that the two enzyme labels are brought into juxtaposition, and introducing the materials (excluding substrate for the second enzyme that is formed by the first enzymic reaction) which allow the enzymic reactions to run, thereby generating a detectable signal in the presence of the target but not in its absence.
Patent AP-9801225-A0 (AP)
Title: Article of clothing.
Inventor: KHEMKA SHEEL
IPC: A41D1/06
Filed: 1997-08-22
Abstract: An article of clothing has a crotch portion separating two leg portions (10, 14, 12, 16)or openings, and having in the crotch portion a croth fly (26)extending along the perineal region, the crotch crotch fly being openable and closable by fastening means (34)which in the closed position are concealed, and, preferably, being provided along a line in the crotch portion in a manner so as to give the appearance of a normal stitched seam in the closed position.
Patent IL-58563-A0 (IL)
Title: Gelated fertilizers process for their manufacture and thei use in plant fertilization
IPC: C05B7/00
Filed: 1979-10-25
Abstract: Water-soluble fertilizer pastes containing 58 to 88% by weight of water-soluble plant nutrients, 0 to 5% by weight of water-soluble micronutrients, 4 to 12% by weight of polyglycol ethers having at least 9 ethylene oxide units and/or water-soluble polyglycol ether derivatives having at least 8 ethylene oxide units per molecule and 8 to 25% by weight of water, process for their manufacture and their use for plant fertilization.
Patent IL-60006-A0 (IL)
Title: 1-hydrocarbyloxyphenyl-1,2-diphenyl-alkene derivatives
IPC: C07C43/235
Filed: 1980-05-06
Abstract: Triphenylalkene derivatives of the formula:  <IMAGE>  wherein R1 is alkenyl, cycloalkenyl, cycloalkenylalkyl, halogenoalkenyl, hydroxyalkyl, dihydroxyalkyl, hydroxycycloalkyl, dihydroxycycloalkyl, hydroxycycloalkylalkyl, epoxyalkyl, alkoxyalkyl or alkylthioalkyl each of up to 10 carbon atoms, wherein R2 is alkyl of up to 6 carbon atoms, halogen or nitro and wherein ring A may optionally bear a halogen substituent or an alkoxy substituent of up to 4 carbon atoms. These compounds possess antioestrogenic activity and are useful in the treatment of anovulatory infertility and of breast tumours. Representative of the compounds is 1-p-allyloxyphenyl-trans-1,2-diphenylbut-2-ene. There are also disclosed processes for the manufacture of the compounds and pharmaceutical compositions containing them.
Patent IL-89871-A0 (IL)
Title: 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
IPC: A61K31/403
Filed: 1989-04-06
Abstract: This invention relates to the use of certain 3-substituted-2-oxindole-1-carboxamides of the formula <CHEM> and the pharmaceutically-acceptable base salts thereof wherein X is H, Cl or F; Y is H or Cl; and R is benzyl or thienyl to inhibit interleukin-1 biosynthesis in a mammal. This invention also relates to the use of such compounds for treating interleukin-1 mediated disorders and dysfunctions such as bone and connective tissue metabolism disorders and immune dysfunction in a mammal. The methods of this invention comprise administering an interleukin-1 biosynthesis inhibiting amount of the compounds and salts of this invention to such a mammal.
Patent IL-92329-A0 (IL)
Title: Virucidal low toxicity composition
IPC: A01N25/30
Filed: 1989-11-16
Abstract: Very potent, stable, odorless, and phenol-free virucidal solutions are active at high dilution when used for surface decontamination of animate and inanimate objects. The virucidal compositions described are efficacious in a matter of minutes against both the lipophilic and the more resistant hydrophilic viruses. The three active ingredients in these virucidal compositions are the glutaraldehyde monomer in equilibrium with its hydrates and polymers, hydrogen-bonded glycol molecules to eliminate aldehydes odor, and an anionic surfactant of the alkyl sulfate, alkyl sulfonate, alcohol sulfate or alkyl aryl sulfonate type. A preferred anionic surfactant would be the Sodium Dodecyl Sulfate (SDS), which exhibits strong cidal synergism against the Herpes Simplex Virus type 1 when mixed at a concentration as low as 0.0005% in diluted glutaraldehyde aqueous solutions (0.0025%). Improved virucidal killing at higher dilutions of the same formula were observed with the more resistant Coxsackie B viruses. Because of the low concentration of active ingredients, these solutions exhibit a very low toxicity, making them suitable for topical applications as antiseptics.
Patent AU-PQ022199-A0 (AU)
Title: Industrial press safety system
IPC: B30B15/00
Filed: 1999-05-05
Abstract: A safety system for an industrial press having a moveable section ( 30 ), the safety means including: a laser emitting means ( 1 ) for emitting a continuous planar laser beam ( 9 ) having a generally constant lateral width; a light receiving means ( 22 ) for receiving the laser beam and for detecting when an object intersects the laser beam; and a control means for stopping or preventing movement of the moveable section of the press when the receiving means detects that the laser beam has intersected an object.
Patent AU-PR157500-A0 (AU)
Title: An apparatus and method (bin02)
IPC: B42C9/00
Filed: 2000-11-20
Abstract: A printer includes a driving station for driving print media between a pair of pinch rollers; a printing station for printing upon the driven print media; an adhesive application station for applying an adhesive to the print media; a collection station for collecting a stack of printed print media bearing adhesive, and including a binding press configured to bind the stack together, the collection station further including a tray having a non-level floor, the tray having a lowermost corner lower than all other corners of the tray; and a vibrator provided beneath the lowermost corner of the tray. At least one of the printing station and the adhesive application station is configured to apply respective fluids to both sides of the print media.
Patent AU-PR448901-A0 (AU)
Title: Improved mooring system
IPC: B63B22/02
Filed: 2001-04-19
Abstract: An offset anchoring system for anchoring objects to a floor of a body of water includes T-shaped anchor members arranged in a cluster. Each anchor member having an elongate first and second beams. The second beam, having longitudinal ends, extends transverse to the first beam. The first beam being disposable in the floor. The system also includes a coupling member to which the anchor members being coupled at respective longitudinal ends such that the substantially T-shaped anchor members are arranged in a cluster with the coupling member being disposed substantially centrally of the anchor members and with the second beams extending substantially radially of the coupling member. When the first beams are driven into the floor and a load is applied to the coupling member, the load is offset from a longitudinal axis of each the first beam thereby increasing the holding power of the anchoring system.
Patent FI-20012290-A0 (FI)
Inventor: PARHI SEPPO
IPC: C07D307/33
Filed: 2001-11-23
Abstract: A method for the production of hydroxymatairesinol or a hydroxymatairesinol complex from wood, including the steps of a) extracting finely divided wood material with a polar solvent, b) optionally concentrating the extract by separating at least part of the solvent, c) adding to the extract an agent able to form a complex with hydroxymatairesinol, d) precipitating the hydroxymatairesinol complex, and optionally e) releasing the hydroxymatairesinol from the complex.
Patent IL-100755-A0 (IL)
Title: X-ray contrast compositions useful in medical imaging
IPC: A61K9/51
Filed: 1992-01-24
Abstract: An X-ray contrast composition comprising particles consisting essentially of a non-radioactive crystalline organic x-ray contrast agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than 400 nm, and a pharmaceutically acceptable carrier therefor is useful in x-ray diagnostic medical imaging methods. The agents can be delivered to a specific tissue or fluid site, for example, the blood pool, liver, spleen, kidney or lymph nodes. In one embodiment involving intravenous administration, preferred compositions provide effective imaging of the blood pool for remarkably long times.
Patent IL-100761-A0 (IL)
Title: Synthesis of intermediates in the preparation of acat inhibitors
IPC: A61K31/47
Filed: 1992-01-24
Abstract: PCT No. PCT/US91/08758 Sec. 371 Date Sep. 13, 1993 Sec. 102(e) Date Sep. 13, 1993 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/13843 PCT Pub. Date Aug. 20, 1992.This invention relates to novel processes for synthesizing intermediates in the preparation of N-aryl and N-heteroarylamide inhibitors of the enzyme acyl coenzyme A: cholesterol acyltransferase (ACAT), and to novel intermediates used in such processes.
Patent IL-103471-A0 (IL)
Title: Compositions and methods for therapy and prevention of cancer,aids and anemia
IPC: A61P31/12
Filed: 1992-10-20
Abstract: A pharmaceutical composition for inhibiting viral replication and spread comprises a pharmaceutically effective amount of a compound of formula I: R<1>R<2>CH-COOH wherein R<1> is selected from H, CH3, CH3-O-, C2H5 or C3H7; R<2> is selected from aryl (formulae of original claim 6) <CHEM> wherein X is independently selected from halogen or hydroxy, and n is 0 to 4; a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and mixtures thereof together with a pharmaceutically acceptable carrier. <IMAGE>
Patent IL-110122-A0 (IL)
Title: Non-reducing oligosaccharide and its production and use
IPC: A23L1/09
Filed: 1994-06-24
Abstract: Novel non-reducing oligosaccharide having a structure represented by the formula of alpha-D-oligoglucosyl alpha-D-oligoglucoside is obtained by exposing either an aqueous solution which contains trehalose and an alpha-glucosyl saccharide or an aqueous solution which contains a non-reducing saccharide bearing a trehalose structure at its end to a saccharide-transferring enzyme. The oligosaccharide has a reduced sweetness, superior stability, appropriate viscosity and less or no susceptibility to crystallization or superior solubility when in crystalline form. These features make the oligosaccharide very useful in various compositions including foods, beverages, cosmetics, pharmaceuticals and shaped bodies.
Patent IL-112736-A0 (IL)
Title: A host-vector system for use in gene therapy
IPC: C12N15/87
Filed: 1995-02-22
Abstract: Host-vector system for expression of a transgene in a target cell or human/animal tissue comprises a eukaryotic cell line transfected with:(a) a recombinant psuedo-retroviral sequence in which all or part of the env gene has been deleted, either totally or partially, and replaced by the transgene as shown in figure 1a, and(b) a nucleic acid sequence which includes a sequence which codes for an envelope protein, is under the control of a promoter, is opt. associated with the transgene and is flanked on its 3' end by a polyadenylation site as shown in figure 1b; provided that(c) both (a) and (b) are capable of trans-complementation to permit the host cell to produce infectious env-deficient virus particles. Also claimed are:(1) a process for the expression of a transgene for gene therapy which comprises:(i) constructing a host-vector system as above;(ii) contacting the system with the cells in which the transgene is to be expressed, and(iii) opt. retransferring the env-contg. sequence into the target cells;(2) a process for the expression of a transgene for gene therapy which comprises the double transfection of target cells with:(i) env-deficient virus particles obtd. using the above host-vector system, and(ii) a nucleic acid sequence contg. a retroviral env gene; where(iii) trans co-expression of the 2 sequences in vivo results in infectious env-deficient recombinant virus particles;(3) a recombinant viral vector contg. a transgene useful in gene therapy, where:(i)a gene essential to the constitution of infectious virus particles is replaced by the transgene;(ii)the essential gene is present on the same or a different vector but is not under the control of viral promoters, and(iii) the prod. of the gene is trans-acting and permits reconstitution of defective virus particles;(4) a medication for use in gene therapy, contg. "vehicles" contg.:(i) a recombinant retroviral sequence in which the env gene is replaced by a trans gene, and(ii) a sequence contg. an env gene under the control of a promoter, where the env-contg. sequence is outside the zone of regulation of the expression of the retroviral sequences, and(5) a medication for use in gene therapy, contg. eukaryotic cells which have been subjected to double transfection and are "represented" by the above host-vector system.
Patent IL-124467-A0 (IL)
Title: Pressure-regulating ear plug
IPC: A61F11/08
Filed: 1996-09-30
Abstract: A pressure regulating ear plug for regulating the rate of change of pressure inside an ear to minimize the pressure differential between the middle ear and a volume of the external ear cavity adjacent the ear drum is made of an ear plug adapted to fit tightly within the external ear cavity with no or minimal air leakage, and disposed within the ear plug is a pressure regulator with a slow leak rate. The pressure regulator is preferably made of a porous ceramic material.